Back to Search
JOHN KREISBERG, MD
MD
Internal Medicine Physician
NPI: 1730297441Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
00022819(AL)
Research & Publications (20)
Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation.
PMID 16606671·J Exp Med·2006
8-other
Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer.
PMID 15289328·Cancer Res·2004
8-other
Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status.
PMID 11507229·J Virol·2001
8-other
Lovastatin inhibits oxidized L-A-phosphatidylcholine B-arachidonoyl-gamma-palmitoyl (ox-PAPC)-stimulated interleukin-8 mRNA and protein synthesis in human aortic endothelial cells by depleting stores of geranylgeranyl pyrophosphate.
PMID 19595352·Atherosclerosis·2010
8-other
Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients with advanced malignancies.
PMID 18202410·J Clin Oncol·2008
3-trial
AKT regulates androgen receptor-dependent growth and PSA expression in prostate cancer.
PMID 18497063·Adv Exp Med Biol·2008
8-other
Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer.
PMID 17896924·Curr Cancer Drug Targets·2007
6-review
A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo.
PMID 17234777·Cancer Res·2007
7-preclinical
In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions.
PMID 17238285·PLoS Pathog·2007
3-trial
Assessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancer.
PMID 17317676·Ann Oncol·2007
8-other
Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation.
PMID 17606718·Clin Cancer Res·2007
8-other
A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells.
PMID 17420725·Oncogene·2007
8-other
Phase I, pharmacokinetic, and biological study of erlotinib in combination with paclitaxel and carboplatin in patients with advanced solid tumors.
PMID 17189413·Clin Cancer Res·2006
3-trial
Human immunodeficiency virus fusion to dendritic cells declines as cells mature.
PMID 16439555·J Virol·2006
8-other
Integrated environmental health clinics: healthcare for people and the environment.
PMID 16781573·Explore (NY)·2005
8-other
Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
PMID 15788644·Endocr Relat Cancer·2005
4-observational
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study.
PMID 15998902·J Clin Oncol·2005
3-trial
Role of protein kinase C in arginine vasopressin-stimulated ERK and p70S6 kinase phosphorylation.
PMID 15048868·J Cell Biochem·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 NORTH EDWARDS STREET
ENTERPRISE, AL 36330 - Phone
- (334) 347-0584
Quick Facts
- NPI
- 1730297441
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile